art8k-08062008.htm
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): August 6, 2008
Arrhythmia
Research Technology, Inc.
(Exact
name of registrant as specified in its charter)
|
Delaware
|
1-9731
|
72-0925679
|
| (State
or other jurisdiction of Incorporation or
organization) |
(Commission
File Number)
|
(I.R.S.
Employer Identification
Number)
|
25 Sawyer
Passway
Fitchburg,
MA 01420
(Address
of principal executive offices and zip code)
(978)
345-5000
(Registrant's
telephone number, including area code)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[ ] Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
[ ] Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
2.02 Results
of Operations and Financial Condition.
On August
6, 2008, Arrhythmia Research Technology, Inc. (the "Company") announced its
financial results for the three and six months ended June 30,
2008. The full text of the press release issued in connection with
the announcement is furnished as Exhibit 99.01 to this Current Report on Form
8-K.
The
information in this Form 8-K and Exhibit 99.01 attached hereto shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934
(the "Exchange Act") or otherwise subject to the liabilities of that section,
nor shall it be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as expressly set forth by
specific reference in such a filing.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits.
| |
Exhibit
No.
|
Description |
| |
|
|
| |
99.01 |
Press Release
dated August 6, 2008 |
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized, in the City of Fitchburg, Commonwealth of Massachusetts, on the
8th day of August, 2008.
|
|
ARRHYTHMIA
RESEARCH TECHNOLOGY, INC.
|
|
|
By: /s/ David A.
Garrison
|
|
|
Executive
Vice President and
|
Exhibit
Index
| Exhibit |
Description |
| |
|
|
99.01
|
Press
Release dated August 6, 2008.
|